What happened with SRTS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Sensus Healthcare supplies equipment that uses low-energy radiation to treat non-melanoma skin cancer and skin conditions such as keloids. Its customers are mainly private dermatology practices and radiation oncologists in private practices and hospitals. Most revenue comes from the SRT-100 product line, related services and ancillary products, with business concentrated in the United States.
Customers can buy the equipment outright or use the Fair Deal Agreement instead. Under that arrangement, Sensus supplies an image-guided treatment system, a radiotherapy technologist and specialist oversight. In return, it receives an agreed share of the reimbursement customers collect for SRT treatments, creating recurring revenue rather than an upfront equipment sale. It also provides services to operate, maintain and repair its devices.
One U.S. customer accounts for more than half of revenue, making its orders especially important. Demand also depends on insurers and government healthcare programs covering treatments and paying enough for clinicians to offer them. Medicare and a number of private insurers currently cover SRT-100 treatments for non-melanoma skin cancer and keloids. Some states require a certificate of need before radiation equipment can be installed. Sensus relies on contract manufacturer RbM Services to produce its SRT-100 systems.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Sensus Healthcare’s results hinge on dermatology practices adopting superficial radiation therapy (SRT), treatment reimbursement and purchases by its historically largest customer—not the unrelated Sensus water-meter business mentioned in several candidate filings.
Sensus Healthcare, Inc earningsThis company
Sensus Healthcare’s report will show whether sales of its SRT systems and related services can recover enough to improve gross profit and cover operating costs.
Read equipment sales and gross margin together, then compare operating expenses. Rising sales, improving margin and controlled expenses would show that customer demand and the cost of serving accounts are moving in the right direction, supporting a recovery in profitability. Weak sales or margin alongside high expenses would show that the core business is not yet generating enough profit to restore it.
